This session will extend the concepts for GCP inspections covered in Session 17 to the post-marketing experience in pharmacovigilance. Several case studies will be discussed.

Have an account?

Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum

Session 28: Audits and Inspections, Part 2

Session Chair(s)

JP Clement, MD

Be informed and stay engaged.